Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy.
Saved in:
| Title: | Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy. |
|---|---|
| Authors: | Cook MM; Oregon Health & Science University, Portland, Oregon, USA., Al Rabadi L; Department of Hematology Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA., Kaempf AJ; Knight Cancer Institute Biostatistics Shared Resource, Oregon Health & Science University, Portland, Oregon, USA., Saraceni MM; Department of Pharmacy, Oregon Health & Science University, Portland, Oregon, USA., Savin MA; Department of Hematology Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA., Mitri ZI; Department of Hematology Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA. |
| Source: | The oncologist [Oncologist] 2021 Feb; Vol. 26 (2), pp. 101-106. Date of Electronic Publication: 2020 Dec 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1002/onco.13609 |
